<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.1d1" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher">REMEDIUM</journal-id><journal-title-group><journal-title>REMEDIUM</journal-title></journal-title-group><issn publication-format="print">1561-5936</issn><issn publication-format="electronic">2658-3534</issn><publisher><publisher-name>Joint-Stock Company Chicot</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1456</article-id><article-id pub-id-type="doi">10.32687/1561-5936-2022-26-3-255-261</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Digital transformation of pharmaceutical companies in the conditions of import substitution</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Koshechkin</surname><given-names>K. A.</given-names></name><bio></bio><email>koshechkin_k_a@staff.sechenov.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ignatiev</surname><given-names>A. A.</given-names></name><bio></bio><email>-</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lebedev</surname><given-names>G. S.</given-names></name><bio></bio><email>-</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Fartushny</surname><given-names>E. N.</given-names></name><bio></bio><email>-</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff id="aff-1">I. M. Sechenov First Moscow State Medical University</aff><aff id="aff-2">Laboratory of Advanced Technologies</aff><pub-date date-type="epub" iso-8601-date="2022-12-15" publication-format="electronic"><day>15</day><month>12</month><year>2022</year></pub-date><volume>26</volume><issue>3</issue><fpage>255</fpage><lpage>261</lpage><history><pub-date date-type="received" iso-8601-date="2022-09-21"><day>21</day><month>09</month><year>2022</year></pub-date></history><permissions><copyright-statement>Copyright © 2022,</copyright-statement><copyright-year>2022</copyright-year></permissions><abstract>The article describes current approaches to the digital transformation of pharmaceutical companies, taking into account the specifics of the requirements of import substitution of software for domestic production systems. Based on publications and open sources of information, the most relevant solutions were selected for the implementation of ERP systems, business analytics, cloud infrastructure, work with big data, the Internet of Things, for robotic automation of processes based on machine learning and artificial intelligence. These systems are analyzed from the point of view of their applicability in the framework of the digital transformation of pharmaceutical companies. Their brief characteristics are given and the purpose is described. The research of the software market showed the availability of affordable solutions of domestic development that can be implemented at a pharmaceutical enterprise to carry out work within the framework of the digital transformation of business processes.</abstract><kwd-group xml:lang="en"><kwd>digital transformation</kwd><kwd>import substitution</kwd><kwd>ERP system</kwd><kwd>business intelligence system</kwd><kwd>cloud infrastructure</kwd><kwd>big data</kwd><kwd>Internet of things</kwd><kwd>robotic process automation</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>цифровая трансформация</kwd><kwd>импортозамещение</kwd><kwd>ERP-система</kwd><kwd>система бизнес-аналитики</kwd><kwd>облачная инфраструктура</kwd><kwd>большие данные</kwd><kwd>интернет вещей</kwd><kwd>роботизированная автоматизация процессов</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Кошечкин К. А., Яворский А. Н. Цифровая биомедицина и биофармацевтика // Ремедиум. 2018. Т. 1-2. С. 16-20.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Blackstone E. A., Fuhr J. P.Jr., Pociask S. The health and economic effects of counterfeit drugs // Am. Heal. Drug Benefits. 2014. Vol. 7, N 4. P. 216-224.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Лебедев Г. С., Фартушный Э. Н., Шадеркин И. А. и др. Создание информационной системы поддержки принятия врачебных решений на основе методов доказательной медицины // Журнал телемедицины и электронного здравоохранения. 2019. Т. 5, № 1. С. 8-16.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Erokhin A., Koshechkin K., Ryabkov I. The distributed ledger technology as a measure to minimize risks of poor-quality pharmaceuticals circulation // PeerJ Comput. Sci. 2020. Vol. 6. P. e292. DOI: 10.7717/peerj-cs.292</mixed-citation></ref></ref-list></back></article>
